Doxazosin Tablet
Product Images NDC 71335-9672

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-9672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Doxazosin 01)

Chemical structure of doxazosin mesylate, a small molecule compound consisting of fused aromatic rings and functional groups including methoxy and amine groups.*

FDA Label Image

Table 3 (Doxazosin 02)

A combined data table and bar graph presenting symptom score and maximum flow rate results from three clinical studies comparing placebo with Doxazosin, including 4 mg and 8 mg doses. The table shows mean baseline, mean change, and sample sizes for symptom scores and maximum flow rate in each group. The adjacent bar graph visualizes maximum flow rate changes in Study 2 for placebo, 4 mg, and 8 mg Doxazosin doses, highlighting statistically significant improvements for the Doxazosin groups compared to placebo.*

FDA Label Image

Figure 1 (Doxazosin 03)

This image shows two line graphs from a clinical study on Doxazosin. The first graph depicts the mean change in total symptom score from baseline over 14 weeks, comparing Doxazosin to placebo. The second graph shows the mean increase in maximum urinary flow rate (mL/sec) from baseline over the same period, also comparing Doxazosin and placebo. Both graphs illustrate treatment duration on the x-axis with corresponding changes on the y-axis.*

FDA Label Image

Label (Lbl713359672)

Label for Doxazosin Mesylate Tablets USP 4 mg oral tablets with package size of 100 tablets. The label includes storage instructions (store at 20° to 25° C), the NDC number 71335-9672-1, repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Upsher-Smith Laboratories, LLC. The label also features barcodes and the BRP Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.